Pelvic Floor Electric Stimulator Market to Hit USD 1.8 Billion by 2031, Driven by Strong North America Leadership at 37% Share | DataM Intelligence

Leander, Texas- The global pelvic floor electric stimulator market was valued $1.1 billion in 2024, depending on the source. It is projected to grow to a value Estimated $1.8 billion by 2030-2031

The market growth is driven by rising awareness of pelvic floor disorders like incontinence, an aging population, and an increasing demand for non-invasive, home-care treatment options. Technological advancements, including portable, wireless devices and mobile app integration, are also boosting market adoption.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/pelvic-floor-electric-stimulator-market?pratik

United states industry development
✅ November 12, 2025: U.S. manufacturers introduced a new generation of pelvic floor electric stimulators featuring wireless connectivity and smartphone app integration, enabling personalized therapy programs and remote monitoring for enhanced patient compliance.

✅ September 18, 2025: A leading U.S. medical device company launched a compact, rechargeable pelvic floor stimulator designed for at-home use, highlighting improvements in electrode materials for better control, patient comfort, and treatment efficacy.

✅ July 5, 2025: U.S. healthcare providers and insurers expanded reimbursement policies for pelvic floor electric stimulation therapies, increasing accessibility for patients with urinary incontinence and pelvic floor disorders.

Japan industry development
✅ October 30, 2025: A prominent Japanese medical device manufacturer released a pelvic floor electric stimulator with AI-driven biofeedback features, optimized for use in clinical and home settings to improve treatment outcomes.

✅ August 15, 2025: Japanese research institutions collaborated with technology firms to develop advanced electrode technology for pelvic floor stimulators that enhances stimulation precision while minimizing discomfort.

✅ June 20, 2025: Japan's Ministry of Health approved new regulatory guidelines facilitating faster market entry for innovative pelvic floor electric stimulation devices meeting stringent safety and efficacy standards.

Recent m&a data:-

⇥Novartis acquired Chinook Therapeutics (2023): Though Chinook focused on rare kidney diseases, this $3.2 billion acquisition highlights big pharma's interest in innovative therapies for conditions affecting the pelvic region and broader urology health, signaling a high valuation for specialized treatments.

⇥Abbott Laboratories partnered with a rehabilitation center (October 2024): Abbott partnered to integrate its pelvic floor therapy devices into patient treatments. This focuses on expanding market reach through strategic collaborations with clinical partners.

⇥Axena Health announced health plan coverage for Leva System (July 2024): Two major U.S. health plans added Axena Health's Leva Pelvic Health System for urinary incontinence to their covered benefits, expanding patient access and potentially boosting sales.

⇥Laborie Medical Technologies and Urotronic Inc. completed procedures in the UK (June 2021): The completion of Optilume procedures shows expansion of advanced minimally invasive urological treatments within the NHS.

🔹 Market segmentation with Market share -

⇥Product Type:
Mobile pelvic floor electric stimulators hold the largest segment share, approximately 63%, due to their portability, ease of use, and growing consumer preference for at-home treatments.

Fixed devices and wearable stimulators form smaller portions of the market, catering more to clinical and long-term monitoring needs.

⇥Application:
Urinary incontinence dominates the application segment, representing the largest share of over 50%, driven by high prevalence among aging populations.

Neurodegenerative disorders and sexual dysfunction segments follow, with sexual dysfunction being a fast-growing niche due to increasing awareness and acceptance.

Other uses include postpartum rehabilitation and pelvic pain management.

⇥End-User:
Hospitals and clinics are the primary end-users, leveraging pelvic floor stimulators as part of therapeutic regimens.

Home care segment is growing rapidly, supported by mobile and wearable stimulator options enhancing patient convenience.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=pelvic-floor-electric-stimulator-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

🔹 Regional insights-

⇥North America:The largest regional market, with approximately 37% share in 2024.
Growth is driven by high awareness of pelvic floor disorders (PFDs), significant healthcare expenditure, the presence of key market players, favorable reimbursement policies for related treatments, and a growing geriatric population that is more susceptible to these conditions.

⇥Asia‐Pacific:A fast-growing region: the market in the Asia-Pacific is projected to grow with the highest CAGR during the forecast period
In the APAC market, China and India are key growth drivers, fueled by rising disposable incomes, improving healthcare infrastructure and awareness, rapid urbanization, and a growing focus on women's health and wellness initiatives.

⇥Europe:A mature market with steady growth: Europe accounts for a significant share, estimated around 27%% of the global market in 2024.
There is strong market penetration, driven by public health initiatives focusing on women's health, an aging population, the high adoption of innovative home-use devices, and established healthcare systems in countries like the U.K., Germany, and France that facilitate access to these products.

🔹 Growth Drivers:-

⇥Increasing Prevalence of Pelvic Floor Disorders:
A significant and growing number of individuals, particularly women, suffer from conditions such as urinary incontinence, pelvic pain, and pelvic organ prolapse. These disorders are often linked to childbirth, menopause, and neurodegenerative diseases.

⇥Rising Geriatric Population:
The global population is aging, and older adults are more susceptible to pelvic health issues. This demographic shift is expanding the potential user base for pelvic floor electric stimulators.

⇥Growing Awareness and Education:
Increased media attention, educational campaigns, and initiatives by health organizations are reducing the stigma associated with pelvic floor problems. This leads more people to seek diagnosis and treatment, driving market demand.

⇥Demand for Non-Invasive Treatments:
Pelvic floor stimulators offer a non-surgical, drug-free alternative for managing pelvic health issues. This makes them a more appealing option for patients who prefer less invasive, low-risk treatments with minimal recovery time.

⇥Technological Advancements:
Innovation has led to more effective, user-friendly, and convenient devices. The development of portable, wireless devices with features like Bluetooth connectivity, biofeedback, and mobile app integration enhances patient engagement and treatment effectiveness.

⇥Shift Towards Home-Based Healthcare:
The rising demand for convenient and affordable home-based treatment solutions, especially following the push for tele-rehab services, has accelerated the adoption of portable electric stimulators that allow users to perform therapy at home.

🔹 Emerging players :-

⇥Axena Health, Inc.: Axena Health is a prominent player known for its
Leva Pelvic Health System, an FDA-cleared, prescription-only device that uses motion-based biofeedback technology for at-home treatment of urinary incontinence.

⇥InControl Medical: This company focuses on non-invasive, at-home pelvic floor devices for various conditions. They are recognized for receiving early over-the-counter (OTC) FDA approval for their devices.

⇥Renovia Inc.: Renovia developed the leva Pelvic Health System, which utilizes a motion-based biofeedback approach to help women strengthen their pelvic floor muscles.

⇥TensCare Ltd.: A UK-based company that offers a variety of pelvic floor stimulators, often sold directly to consumers. Their focus is on convenient, non-invasive, and affordable options for managing pelvic floor issues at home.

⇥Athena Feminine Technologies, Inc.: A smaller, focused company that has been active in the pelvic health space, offering products like the "Intensity" pelvic floor trainer.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/pelvic-floor-electric-stimulator-market?pratik

🔹 Key Investment:

Livanova PLC invested approximately USD 15 million in R&D to enhance device functionalities and market reach.

PelviPower invested around USD 7 million focused on expanding its product line of wearable pelvic floor electrical stimulators, aiming to capture the at-home therapy segment.

Atlantic Therapeutics raised USD 25 million in Series C funding in mid-2025 to scale commercialization of its non-invasive pelvic floor stimulation devices incorporating AI and biofeedback technologies.

Medtronic PLC invested around USD 30 million enhancing electrode materials and integrating wireless connectivity for better patient compliance.

Other notable investments include startups focusing on app-based and IoT-enabled pelvic floor stimulators raising between USD 1 million to 10 million to accelerate product development and market launch.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.